NDC 46066-219 - CMPK

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 46066-219
Package NDCs from labels: 46066-219-25
Manufacturer: Aspen Veterinary Resources, Ltd.
Effective date: 2018-04-26
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
CMPK Solution	Aspen Veterinary Resources, Ltd.	2018-04-26	OTC ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
46066-219-25	CMPK	500 mL in 1 BOTTLE	SOLUTION	500		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
46066-219	CMPK (CALCIUM PHOSPHORUS MAGNESIUM POTASSIUM DEXTROSE) SOLUTION [ASPEN VETERINARY RESOURCES, LTD.]	1	1 package rows	20180426_33a63540-a72e-4843-a6dd-08f29ed27096.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 58 of 60 · 1,193 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lactated Ringers	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE	Asclemed USA, Inc.	afac6cc5-1ced-4639-b6f6-86f40ef5c30e	2020-10-29	Warnings, Adverse reactions	Exact identifier unii: 660YQ98I10
POTASSIUM CHLORIDE IN DEXTROSE	DEXTROSE AND POTASSIUM CHLORIDE	B. Braun Medical Inc.	e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23	2020-07-31	Warnings, Adverse reactions	Exact identifier unii: 660YQ98I10
Cardioplegic	CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM CHLORIDE	Baxter Healthcare Corporation	1fd50ce5-2799-4c26-81da-02cf0578dd9e	2020-06-11	Warnings, Adverse reactions	Exact identifier unii: 02F3473H9O unii: 660YQ98I10
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	ee831456-5962-4d5e-ad0c-69ab85860453	2020-06-03		Exact identifier unii: LX22YL083G
LACTATED RINGERS AND DEXTROSE	SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE	HF Acquisition Co LLC, DBA HealthFirst	a62cf623-9b8a-37e0-e053-2995a90add5b	2020-05-21	Warnings, Adverse reactions	Exact identifier unii: 660YQ98I10 unii: LX22YL083G
DEXTROSE AND SODIUM CHLORIDE	DEXTROSE MONOHYDRATE, SODIUM CHLORIDE	Fresenius Kabi USA, LLC	b825c9c4-f2fb-4a4a-9d8c-fb020ad07e93	2020-04-30	Warnings, Adverse reactions	Exact identifier unii: LX22YL083G
Potassium Chloride	POTASSIUM CHLORIDE	Genus Lifesciences Inc.	23d818e7-c076-40de-8dc1-0b51ba4be96a	2020-04-28	Warnings, Adverse reactions	Exact identifier unii: 660YQ98I10
Potassium Chloride	POTASSIUM CHLORIDE	Lupin Pharmaceuticals,Inc.	1bbacdbb-91fa-4897-a00c-1b293de27b83	2020-04-27	Warnings, Adverse reactions	Exact identifier unii: 660YQ98I10
Potassium Chloride	POTASSIUM CHLORIDE	Mylan Pharmaceuticals Inc.	c64ed4c0-1e27-42b3-9625-fb4e0d31e271	2020-04-15	Warnings, Adverse reactions	Exact identifier unii: 660YQ98I10
Dextrose	DEXTROSE MONOHYDRATE	Baxter Healthcare Company	7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e	2020-02-27	Warnings, Adverse reactions	Exact identifier unii: LX22YL083G
Dextrose and Electrolyte No. 48	SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE	Baxter Healthcare Company	b283a454-0c20-4fbf-92d3-dae1f3cd3cad	2020-02-13	Warnings, Adverse reactions	Exact identifier unii: 02F3473H9O unii: 660YQ98I10 unii: LX22YL083G
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	e41adb4e-06fb-4141-ba55-50b043f3c9da	2019-11-19		Exact identifier unii: LX22YL083G
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	14445dfd-6041-40cd-a043-3f4da6bcb9c1	2019-11-18		Exact identifier unii: LX22YL083G
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	2557199a-5f60-49d8-b093-1e0700211243	2019-11-18		Exact identifier unii: LX22YL083G
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	794f724c-87f0-49c1-9b26-c9e491978313	2019-11-18		Exact identifier unii: LX22YL083G
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	5c7d3287-883a-459b-9214-074a583c8a59	2019-11-18		Exact identifier unii: LX22YL083G
CPDA-1	ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE	Fenwal, Inc.	448a1dc5-7a98-4b2f-82af-4b92de05cfc3	2019-11-18		Exact identifier unii: LX22YL083G
Plasma-Lyte A	SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE	Baxter Healthcare Corporation	6ec9e61c-2c26-402f-8604-f446b2e34058	2019-08-05	Warnings, Adverse reactions	Exact identifier unii: 02F3473H9O unii: 660YQ98I10
DEXTROSE	DEXTROSE MONOHYDRATE	Baxter Healthcare Corporation	0332f34a-7038-47cc-ba59-d55cad6b73ca	2019-08-05	Warnings, Adverse reactions	Exact identifier unii: LX22YL083G
Potassium Chloride in Dextrose	POTASSIUM CHLORIDE AND DEXTROSE MONOHYDRATE	Baxter Healthcare Company	45de5402-5e61-4bbd-8bbc-5e3392c9920e	2019-07-15	Warnings, Adverse reactions	Exact identifier unii: 660YQ98I10 unii: LX22YL083G

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.